Moderna lifts annual revenue forecast on strong COVID vaccine demand overseas

1

Nov 6 (Reuters) – Moderna lifted its full-year revenue forecast on Friday after strong international COVID-19 vaccine demand and payments from partnerships helped the biotech swing to profit in the

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)